Procarbazine Export Market Intelligence: India's 84 Suppliers Shipping to 53 Countries — TransData Nexus 2026

Q: Who are the top procarbazine exporters from India?

The top procarbazine exporters from India are: 1. SUNMOON CHEMICALS PRIVATE LIMITED — $68.2K (25.8% market share); 2. 3S CORPORATION — $39.2K (14.9% market share); 3. IKRIS PHARMA NETWORK PRIVATE LIMITED — $13.9K (5.3% market share); 4. NEON LABORATORIES LIMITED — $13.3K (5.0% market share); 5. ZYPHAR'S PHARMACEUTICS PRIVATE LIMITED — $9.2K (3.5% market share). Together they account for 54.4% of India's total procarbazine export value.

Q: What is the total export value of procarbazine from India?

The total export value of procarbazine from India is $264.2K USD, recorded across 318 shipment transactions from 84 active exporters to 53 destination countries. The average shipment value is $831.

Q: Which countries import procarbazine from India?

India exports procarbazine to 53 countries worldwide. The top importing countries are: UKRAINE (25.9% share, $68.3K), TURKEY (13.8% share, $36.6K), BRAZIL (7.5% share, $19.9K), MALAYSIA (5.6% share, $14.8K), POLAND (5.5% share, $14.6K). These five markets account for 58.3% of total export value.

Q: What is the HS code for procarbazine exports from India?

The primary HS code for procarbazine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of procarbazine exports from India?

The average unit price for procarbazine exports from India is $102.88 USD per unit, with prices ranging from $0.10 to $25274.73 depending on formulation, packaging, and order volume. The total market is valued at $264.2K across 318 shipments.

Q: Which ports handle procarbazine exports from India?

The primary ports for procarbazine exports from India are SAHAR AIR (36.2% of shipments), SAHAR AIR CARGO ACC (INBOM4) (25.8% of shipments), Bombay Air (9.1% of shipments), DELHI AIR (6.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (4.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of procarbazine?

India is one of the world's leading exporters of procarbazine due to its large base of 84 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports procarbazine to 53 countries, demonstrating 27% global market coverage.

Q: What certifications do Indian procarbazine exporters need?

Indian procarbazine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import procarbazine from India?

There are 144 registered buyers importing procarbazine from India, spread across 53 countries. The repeat buyer rate is 29.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top procarbazine supplier from India?

SUNMOON CHEMICALS PRIVATE LIMITED is the leading procarbazine exporter from India with a market share of 25.8% and total export value of $68.2K across 3 shipments. The top 5 suppliers together control 54.4% of total export value.

Suresh Sormare

Procarbazine

India Pharmaceutical Trade Intelligence

$264.2K84 Suppliers53 CountriesHS 30049049

ExportsIndia → UKRAINE25.9%India → TURKEY13.8%

#1 Buyer: TO THE

Procarbazine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Procarbazine to the World

Between 2022 and 2026, India exported $264.2K worth of procarbazine across 318 verified shipments to 53 countries — covering 27% of world markets in the Advanced Oncology segment. The largest destination is UKRAINE (25.9%). SUNMOON CHEMICALS PRIVATE LIMITED leads with a 25.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Procarbazine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Procarbazine export data snapshot — $264.2K · 84 exporters · 53 countriesTransData Nexus · Indian Customs Data

Top Procarbazine Exporters from India

84 active exporters · Ranked by export value

View all 84 →

Top Procarbazine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUNMOON CHEMICALS PRIVATE LIMITED	$68.2K	3	1	25.8%
2	3S CORPORATION

Top Countries Importing Procarbazine from India

53 destination markets · Ranked by import value

All 53 countries →

Top Countries Importing Procarbazine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UKRAINE	$68.3K	25.9%
2	TURKEY	$36.6K	13.8%
3	BRAZIL	$19.9K	7.5%
4	MALAYSIA	$14.8K	5.6%
5	POLAND	$14.6K	5.5%
6	UNITED ARAB EMIRATES	$13.9K	5.2%
7	PAKISTAN	$10.0K	3.8%
8	UNITED KINGDOM	$9.8K	3.7%
9	LITHUANIA	$8.7K	3.3%
10	MOLDOVA	$8.4K	3.2%

UKRAINE is India's largest procarbazine export destination, absorbing 25.9% of total exports worth $68.3K. The top 5 importing countries — UKRAINE, TURKEY, BRAZIL, MALAYSIA, POLAND — together account for 58.3% of India's total procarbazine export value. The remaining 48 destination countries collectively receive the other 41.7%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Procarbazine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Procarbazine, an antineoplastic agent, has been approved in the United States for the treatment of Hodgkin's lymphoma. According to the FDA's Orange Book, there are multiple approved Abbreviated New Drug Applications (ANDAs) for procarbazine hydrochloride capsules, indicating the presence of generic versions in the market. The most recent ANDA approval was granted in March 2025. As of March 2026, there are no active FDA import alerts specifically targeting procarbazine or its manufacturers, suggesting compliance with FDA regulations among current suppliers.

Given the presence of 84 active Indian exporters and 318 shipment records from 2022 to 2026, it is evident that Indian manufacturers play a significant role in supplying procarbazine to the U.S. market. The average Free on Board (FOB) unit price of $102.88 underscores the competitive pricing offered by Indian exporters. This robust participation aligns with the FDA's regulatory framework, which facilitates the entry of generic drugs through the ANDA pathway, provided they meet stringent quality and safety standards.

2EU & UK Regulatory Framework

In the European Union, procarbazine is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). Manufacturers must obtain approval to market procarbazine within EU member states, ensuring compliance with the EU's Good Manufacturing Practice (GMP) standards. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates the authorization and monitoring of medicinal products, including procarbazine. Compliance with these regulatory bodies ensures that procarbazine meets the necessary safety, efficacy, and quality standards for distribution within these regions.

3WHO Essential Medicines & Global Standards

Procarbazine is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in treating Hodgkin's lymphoma. The drug is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality specifications across different regions. However, as of March 2026, procarbazine has not been prequalified by the WHO Prequalification Programme, which primarily focuses on medicines for high-burden diseases such as HIV/AIDS, malaria, and tuberculosis.

4India Regulatory Classification

In India, procarbazine is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for procarbazine, allowing market-driven pricing. For export purposes, Indian manufacturers are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The primary patents for procarbazine have expired, leading to the availability of generic versions in various markets. This expiration has fostered increased competition among manufacturers, including the 84 active Indian exporters, thereby contributing to more affordable treatment options for patients globally.

6Recent Industry Developments

In October 2025, the FDA updated its import alerts to reinforce that all unauthorized e-cigarettes may be detained without physical examination. While this action does not directly impact procarbazine, it reflects the FDA's ongoing efforts to regulate imported products rigorously. Additionally, in January 2025, the FDA announced the update of two import alerts, 98-07 and 98-06, to provide clearer instructions to FDA staff and the trade community regarding unauthorized e-cigarette products. These updates aim to prevent unauthorized products from entering the U.S. market, ensuring compliance with FDA regulations.

Furthermore, in March 2025, the FDA approved a new generic version of procarbazine hydrochloride capsules, expanding treatment options for patients with Hodgkin's lymphoma. This approval underscores the FDA's commitment to facilitating access to essential medications through the approval of generic drugs.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Procarbazine

Retail & reference prices across 9 markets vs. India FOB export price of $102.88/unit

Global Price Benchmark for Procarbazine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$29.00	USD	Pricing data sourced from PharmacyChecker-accredited online pharmacies.
United Kingdom	N/A	GBP	Specific pricing information for Procarbazine is not readily available through public NHS sources.
Germany	N/A	EUR	Specific pricing information for Procarbazine is not readily available through public sources.
Australia	N/A	AUD

Supply Chain Risk Assessment — Procarbazine

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Procarbazine, an antineoplastic agent, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) imported from China. This dependency is part of a broader trend where approximately 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, as reported by the U.S. Pharmacopeia in November 2025.

The reliance on Chinese KSMs introduces significant vulnerabilities. For instance, in September 2020, China increased prices of key drug materials by 10-20%, impacting the cost structures of Indian pharmaceutical manufacturers. Such price fluctuations and potential supply disruptions underscore the risks associated with this dependency.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of Procarbazine account for 54.4% of total exports, with SUNMOON CHEMICALS PRIVATE LIMITED alone contributing 25.8%. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global supply chains.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing import dependence on critical pharmaceutical ingredients. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a step towards self-reliance. However, the effectiveness of these initiatives in diversifying Procarbazine's supply base remains to be seen.

Access Complete Procarbazine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 318 transactions across 53 markets.

Request Demo View Pricing

Frequently Asked Questions — Procarbazine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top procarbazine exporters from India?

The leading procarbazine exporters from India are SUNMOON CHEMICALS PRIVATE LIMITED, 3S CORPORATION, IKRIS PHARMA NETWORK PRIVATE LIMITED, and 7 others. SUNMOON CHEMICALS PRIVATE LIMITED leads with 25.8% market share ($68.2K). The top 5 suppliers together control 54.4% of total export value.

What is the total export value of procarbazine from India?

The total export value of procarbazine from India is $264.2K, recorded across 318 shipments from 84 active exporters to 53 countries. The average shipment value is $831.

Which countries import procarbazine from India?

India exports procarbazine to 53 countries. The top importing countries are UKRAINE (25.9%), TURKEY (13.8%), BRAZIL (7.5%), MALAYSIA (5.6%), POLAND (5.5%), which together account for 58.3% of total export value.

What is the HS code for procarbazine exports from India?

The primary HS code for procarbazine exports from India is 30049049. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Procarbazine

Procarbazine

How India Exports Procarbazine to the World

Top Procarbazine Exporters from India

Top Countries Importing Procarbazine from India

Quick Facts

Related Advanced Oncology

Related Analysis

Need Details?

Regulatory Landscape — Procarbazine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Procarbazine

Supply Chain Risk Assessment — Procarbazine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Procarbazine Trade Intelligence

Frequently Asked Questions — Procarbazine Exports from India

Who are the top procarbazine exporters from India?

What is the total export value of procarbazine from India?

Which countries import procarbazine from India?

What is the HS code for procarbazine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of procarbazine exports from India?

Which ports handle procarbazine exports from India?

Why is India a leading exporter of procarbazine?

What certifications do Indian procarbazine exporters need?

How many buyers import procarbazine from India?

What is the market share of the top procarbazine exporter from India?

Analysis Methodology